Type III cartilage "shield" tympanoplasty: an effective procedure for hearing improvement

Chronic otitis media often leads to hearing loss due to structural damage in the middle ear. Traditional interventions include ossicular reconstruction and tympanic membrane repair. However, when the incus is absent and space is limited, conventional methods may not be suitable. Prior research has shown that partial ossicular replacement prosthesis can be effective in some cases. Yet, there remains a gap in managing patients with both a missing incus and restricted anatomical space. This uncertainty drove the exploration of alternative reconstructive techniques. The use of cartilage grafts has been proposed in various forms, but their application in this specific context is less established. No prior work had resolved the effectiveness of cartilage-based reconstruction in such complex anatomical scenarios. This gap motivated the investigation of a novel cartilage shield technique. The study aimed to address this unmet need in reconstructive surgery.

The aim of this study was to evaluate the effectiveness of type III cartilage 'shield' tympanoplasty in patients with chronic otitis media and limited middle ear space. Specifically, the focus was on those with an absent incus and a diminished gap between the stapes and malleolar manubrium. The motivation stemmed from the limitations of existing prosthetic options in such anatomical conditions. The researchers sought to determine whether this cartilage-based approach could achieve comparable hearing outcomes. The study was conducted at a tertiary referral center to ensure access to complex cases. The goal was to assess graft success rates and hearing improvement metrics. The primary outcome was postoperative hearing improvement measured in decibels. The secondary outcome was the proportion of patients achieving a specific air-bone gap reduction.

The study employed a retrospective chart review at a tertiary referral center. The sample included 52 patients who underwent type III cartilage 'shield' tympanoplasty between January 1998 and June 2005. The mean patient age was 32.4 years, with a follow-up period averaging 24 months. The surgical technique involved using conchal cartilage shaped into a shield to replace the tympanic membrane and reconstruct the ossicular chain. The cartilage was positioned to bridge the gap between the stapes and malleolar manubrium. Graft success was evaluated based on postoperative imaging and audiometric outcomes. Hearing improvement was quantified using pre- and postoperative air-bone gap measurements. The study also tracked complications and speech discrimination scores to assess functional outcomes.

The results indicated a successful graft take in all 52 patients. The average hearing improvement was 11.22 dB, with statistical significance (P<0.0001). Forty-one patients (78.8%) achieved an air-bone gap of 25 dB or less. Speech discrimination scores remained stable, showing no decline. The mean follow-up period was 24 months, with no reported complications. These findings suggest that the cartilage shield technique can effectively restore hearing in this patient group. The hearing outcomes were comparable to those achieved with partial ossicular replacement prosthesis. The absence of complications further supports the safety of this approach.

The authors concluded that type III cartilage 'shield' tympanoplasty is an effective technique for hearing improvement in selected patients with chronic otitis media. The procedure was associated with a high success rate and significant audiometric gains. The results were similar to those obtained with partial ossicular replacement prosthesis, suggesting a viable alternative. The absence of complications supports the safety profile of this method. The study highlights the potential of cartilage-based reconstruction in complex anatomical cases. The findings are specific to patients with an absent incus and limited middle ear space. The authors propose that this technique should be considered in similar clinical scenarios. No broader generalizations are made beyond the study population.